newsfilter
← Latest News
GlobeNewswire·

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

-- VAX-31 Infant Indication: Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 -- -- VAX-31 Adult Indication: Breakthrough Therapy